En
glis
h
13
3. Safety information
Definitions
Read the safety statements before use of the
physiotherapy unit. The safety statements are
classified as follows:
m
Danger!
indicates an imminent hazard. If not avoided,
this hazard will result in death or serious injury.
m
Warning!
indicates a hazard. If not avoided, the hazard
can result in death or serious injury.
m
Caution!
indicates a potential hazard. If not avoided,
the hazard may result in minor injury and/or
product/property damage.
Safety information
m
Danger!
Explosion hazard — The ARTROMOT®
ACTIVE-K is not designed for use in areas of
rooms used for medical purposes where an
explosion hazard may occur. An explosion
hazard may result from the use of flammable
anesthetics, skin cleansing agents, and
disinfectants.
m
Warning!
Patient hazard —
− Only authorized individuals are allowed
to operate the ARTROMOT® ACTIVE-K.
Individuals are authorized after receiving
training in the operation of the unit and
reading this operation manual.
− Before using the device, the operator must
ascertain that it is in correct working order
and operating condition.
The cables and connectors, in particular,
must be checked for signs of damage. Dam-
aged parts must be replaced immediately,
before use.
− Before therapy, a test run consisting of sev-
eral exercise cycles must be completed, first
without and then with the patient. Check
that all setting screws are tightened.
− Stop therapy immediately when you have
doubts about the device settings and/or
the therapy protocol.
− It is important that the patient's position is
anatomically correct. Therefore, carefully
verify the following settings/positions:
1. femur length
2. knee joint axis
3. tibia length and leg rotation
4. leg support assemblies
− Movements must not cause pain or
irritation.
− Patients must be fully conscious while
being instructed in the use of the physio-
therapy unit and during therapy.
− Only the responsible physician or therapist
is able and allowed to choose the therapy
parameters and protocols to use. It is the
physician's or therapist's decision whether
or not to use the unit on a specific patient.
− The patient must be familiar with the func-
tions of the ARTROMOT® ACTIVE-K control
pendant and the pendant must always be
within easy reach of the patient, allowing
him or her to stop treatment if needed.
Patients unable to operate the control pen-
dant, e.g. paralytic patients, must always be
supervised by specially trained staff during
therapy.
− After data storage, write the patient's name
on the patient chip card. The card should
only be used for this particular patient.
If the patient chip card is used for another
patient, be sure to delete the previous
patient's data from the card first (see: "New
Patient", section 5.3.2).
Use original chip cards only.
− Any accessories used with the ARTROMOT®
ACTIVE-K must first be approved by DJO
Global.
− Modifications to the medical device de-
scribed in this document without the man-
ufacturer's written consent is prohibited.
Supplied by EME Services Ltd
